Primary cell culture planned around the donor, not the protocol

Planning primary work and the cell culture supplies it needs

1. Settle provenance and consent before sourcing. Material from people comes with a consent scope, an ethics approval and a chain of custody. Establish what the consent permits, who holds the approval covering your use, and what the supplier can document, because a study built on material whose consent does not cover the work cannot be published or used.
2. Choose fresh or cryopreserved deliberately. Fresh material gives the closest thing to the in vivo state and forces the experiment to run on the supplier's schedule. Cryopreserved vials give control of timing and lose a fraction of viability and some functional responses. Neither is better; the choice should follow whether the readout is sensitive to what freezing changes.
3. Fix the isolation method and keep it fixed. Density separation, negative selection and positive selection each leave a different population, and positive selection leaves an antibody bound to the marker used. Comparing across methods compares methods. Choose one, document it, and note it in every result.
4. Plan for donor variation in the design. Donor to donor differences frequently exceed the effect under study. Use several donors rather than several wells from one, treat donor as a blocking factor in the analysis, and record donor characteristics that could plausibly matter.
5. Match medium, coating and passage limit to the cell. Primary cells have finite lifespans and change with passage. Establish the passage limit at which the phenotype still holds, write it into the protocol, and match the coating and medium to the cell type rather than to whatever the laboratory has.
6. Handle at the containment the material requires. Human derived material is handled as potentially infectious, with the precautions that implies for the people doing it. Confirm the containment level, the waste route and the vaccination requirements before the first delivery.

The donor is the variable

A cell line is one genotype cultured indefinitely; primary material is a person, and the population you receive reflects their biology and the day they donated. That is exactly why primary cells are used, and it means the statistics have to treat donor as a real source of variation rather than as noise to average away.

Design with donors as the unit of replication. Wells within a donor tell you about technical precision; donors tell you whether the effect exists in people, which is usually the question.

Scheduling is part of the specification

Fresh material arrives when the collection happens, not when the laboratory is ready, and the useful window is short. That makes reagent preparation, plate coating and instrument booking part of the order rather than something arranged afterwards.

Where a study cannot absorb that unpredictability, cryopreserved vials from a characterised donor set are the pragmatic choice, and the loss in fidelity should be stated rather than ignored.

What an automated cell culture system actually fixes

Isolation and feeding are the steps where operator technique changes yield, purity and phenotype, and they are exactly the steps automated systems standardise. For laboratories running the same isolation repeatedly, that consistency is worth more than the throughput.

It does not fix donor variation, and it does not remove the need to characterise what came out. Automation makes the process repeatable; it does not make the material uniform.

Donor, passage and the window a primary cell works in

A primary cell is a finite resource with a donor, a passage limit and a phenotype that drifts toward something less like the tissue with every division. The useful experimental window is early, and it is shorter than most protocols assume.

Record the donor, the lot and the passage in every experiment, use several donors where the conclusion is about people rather than about cells, and bank early. A primary culture carried to a high passage has quietly become a different model.

Neurons, and what a culture of them is

Rodent primary neurons come from embryonic or neonatal tissue, cannot divide and need a defined medium, a coated surface and often a glial feeder layer. They are the reference model, and they are rodent and embryonic, which are two differences from adult human neurons.

Neurons differentiated from stem cells carry a human genotype and can be produced repeatedly, and they are usually immature compared with adult tissue, with the maturation protocol mattering as much as the starting cells. Both are legitimate and neither is adult human brain.

Cell culture services: making the model rather than buying it

Reprogramming somatic cells to a pluripotent state, then differentiating them, gives a model carrying a donor's genotype in the cell type of interest. Editing at a locus in that background gives an isogenic comparison that no pair of unrelated lines can match.

It is a project rather than a purchase: reprogramming, characterisation, karyotype, differentiation protocol development and batch-to-batch variability all have to be handled. Buying a characterised line or a differentiated preparation is usually faster and often cheaper than making one.

Isolating peripheral blood mononuclear cells from blood and marrow

Mononuclear cells are separated from blood on a density gradient, which is cheap and gives a mixed population, and yield and viability depend heavily on the time from draw to processing. Anticoagulant choice and temperature matter as much as technique.

Marrow-derived macrophages are not isolated but differentiated: progenitors are flushed out and cultured with a growth factor for several days, and the resulting cells depend on the factor, its source and the duration. Two laboratories using different factors have two different models.

Magnetic selection against a gradient

Labelling a population with an antibody on magnetic particles and retaining it in a field gives far higher purity than a gradient and preserves viability better than sorting. Negative selection leaves the cells of interest untouched, which matters when a label would activate them.

The consumable cost is real and the throughput is limited by column capacity, so a gradient remains the right first step to reduce the sample before selection. The two are usually used together rather than as alternatives.

Primary mouse hepatocytes, and the first forty-eight hours

Primary hepatocytes are the demanding end of primary culture: freshly isolated cells that plate on a collagen coated surface, lose cytochrome expression over days and dedifferentiate if the format lets them. What decides an experiment is the first two days, the attachment period in a serum-containing medium, then a serum-free maintenance medium with the overlay or sandwich configuration the assay needs, and a viability figure recorded on arrival rather than assumed. Cryopreserved lots are convenient and plate at a lower efficiency, so the plating density has to be set against the lot's own post-thaw count.

stem cell reagents and what the phrase covers

stem cell reagents means the media, the matrix, the growth factors and the small molecules a protocol names, and the reagent that most often decides an outcome is the matrix rather than the medium. Lot reservation matters because differentiation efficiency varies between lots, and a protocol that names brands rather than components is difficult to reproduce elsewhere.

rat neurons and what a primary culture gives

rat neurons arrive as a dissociated preparation with a stated viability and embryonic age, and they do not divide, so plating density is the experiment and every comparison is between preparations. The substrate coating, the medium supplement and the days in culture decide the phenotype, which is why those three belong in every method rather than the species alone.

Common questions

How many donors does an experiment need?

Enough that a conclusion is not a property of one person. Three is a common minimum for exploratory work and frequently too few when variation is large; the honest answer comes from the variation observed in a pilot rather than from convention.

Does positive selection change the cells?

It can. An antibody bound to a surface marker may signal through it, and residual beads affect downstream steps. Negative selection avoids this at the cost of lower purity, which is the trade to make consciously.

Why do results differ between vial lots?

Because a lot is a donor. Differences in genotype, age, health, collection and processing all travel with the vial. Buying several vials from one donor lot lets a study run without confounding donor with experimental group.

What documentation should arrive with the material?

Donor identifier or code, consent scope, the collection and processing dates, the isolation method, viability, purity by a stated method, and any donor characteristics the supplier is permitted to share. Anything less makes the material hard to defend later.

How long can I culture a primary cell?

Less time than most protocols assume. Phenotype drifts with every division, so the useful window is early. Record donor, lot and passage, bank early, and use several donors where the conclusion is about people.

Should I make my own stem-cell-derived model?

Only if the genotype is the point and no characterised line exists. Reprogramming, characterisation, karyotype and differentiation development are a project; buying a characterised line or preparation is usually faster and cheaper.

Browse by service class

• Compare Gene synthesis on advertised prices